Cyvex Nutrition has announced that its Chirositol™, an extract from carob juice containing the active constituent D-Chiro-Inositol, has been repositioned to lead the market niche in blood sugar control products targeted for women.
D-Chiro-Inositol has a known role as a secondary messenger directing insulin function. Poor blood sugar management can be linked to a number of conditions such as diabetes type 2, obesity, and Polycystic Ovary Syndrome (PCOS). Chirositol™ brand of D-Chiro-Inositol has been the subject of more than 30 published scientific studies describing its role in blood sugar management.
“We have experienced outstanding success with supplements containing Chirositol™,” said Matt Phillips, president and COO of Cyvex. “We understand that women are the primary buyer of these products and are now focusing on expanding sales by securing additional supplement manufacturers to license the ingredient for major new product launches."
Phillips adds that the success of the initial products can be attributed to viral marketing. Supplements containing Chirositol have largely been marketed on the internet. “Several popular blogs about women's health issues have published favorable mentions of Chirositol™ fueling additional growth. We feel Chirositol™ represents a significant opportunity for a natural health retailer or mass market supplement brand since there is significant supporting scientific data. "
A technical summary and study references are available by calling Cyvex Nutrition 949-622-9030 or through e-mail at [email protected].
For more information, visit Cyvex Nutrition’s web site at http://www.cyvex.com. Follow Cyvex on Twitter and on Facebook.